# Safety and Immunogenicity of Sars-cov-2 Vaccine in Patients With Rheumatic Diseases

> **NCT05191368** · — · UNKNOWN · sponsor: **Yunnan University of Chinese Medicine** · enrollment: 500 (estimated)

## Conditions studied

- Rheumatic Disease

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT05191368
- **Lead sponsor:** Yunnan University of Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-12
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-06-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05191368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05191368, "Safety and Immunogenicity of Sars-cov-2 Vaccine in Patients With Rheumatic Diseases". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05191368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*